PATENT CLAIM ANALYSIS

Application Number: 15904254
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["530", "350000"]

Abstract:
Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or fragments thereof that provide specific binding, to erythrocytes. The peptides may be prepared as molecular fusions with therapeutic agents, tolerizing antigens, or targeting peptides. Immunotolerance may be created by use of the fusions and choice of an antigen on a substance for which tolerance is desired.

Claim (Index 10):
The composition of  claim 9 , wherein the antigen is a food antigen to which a subject develops an unwanted immune response, wherein the food antigen is associated with celiac disease, and wherein the food antigen is selected from the group consisting of high molecular weight glutenin, low molecular weight glutenin, gliadin, hordein, secalin, avenin, and immunogenic fragments thereof, and immunogenic mimotopes thereof.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 88.0
- Lexical Diversity: 1.38182
- Patent Class: 530.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15232713', '15904248', '15904228', '15232724', '15232714']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8661028557962046
- 35 USC 102 Novelty (BERT): 0.6282920138933709
- Combined Prediction Score: 0.8423217716059213
- Mean Citation Score: 727.8368780000003
- Max Citation Score: 790.30615
- Similarity Product: 527.5694573345453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test